Biocept Total Assets 2011-2026 | BIOC

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets Biocept

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
30.9 M	60.4 M	47.5 M	17.7 M	8.75 M	7.38 M	7.58 M	10.6 M	6.59 M	1.33 M	1.47 M	2.06 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
60.4 M	1.33 M	16.9 M

Quarterly Total Assets Biocept

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
22.1 M	23 M	30.9 M	51.1 M	58.1 M	61.9 M	60.4 M	61.9 M	50.6 M	50.3 M	47.5 M	47.5 M	47.5 M	47.5 M	17.7 M	17.7 M	17.7 M	17.7 M	8.75 M	8.75 M	8.75 M	8.75 M	7.38 M	7.38 M	7.38 M	7.38 M	7.58 M	7.58 M	7.58 M	7.58 M	10.6 M	10.6 M	10.6 M	10.6 M	6.57 M	6.57 M	6.57 M	6.57 M	1.33 M	1.33 M	1.33 M	1.33 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
61.9 M	1.33 M	21.4 M

Total Assets of other stocks in the Diagnostics research industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	85.8 M	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	77.2 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	586 M	-	-	$ 1.31 B	USA
Celcuity CELC	467 M	$ 88.57	-4.22 %	$ 4.14 B	USA
Akumin AKU	1.77 B	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	24.7 M	$ 5.32	-7.68 %	$ 7.08 M	USA
Castle Biosciences CSTL	579 M	$ 21.2	-1.85 %	$ 615 M	USA
Fulgent Genetics FLGT	1.21 B	$ 19.02	-2.46 %	$ 585 M	USA
Aspira Women's Health AWH	5.46 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	28.6 M	-	-61.36 %	$ 2.46 M	USA
Guardant Health GH	2.01 B	$ 126.28	-5.1 %	$ 15.8 B	USA
Interpace Biosciences IDXG	33.8 M	$ 1.65	-7.82 %	$ 7.3 M	USA
Oxford Immunotec Global PLC OXFD	235 M	-	-	$ 562 M	Britain
CareDx, Inc CDNA	413 M	$ 22.06	-4.58 %	$ 1.18 B	USA
Illumina ILMN	6.64 B	$ 161.86	-3.69 %	$ 25.1 B	USA
Chembio Diagnostics CEMI	62.6 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	7.49 M	-	-	$ 9.42 M	Israel
ICON Public Limited Company ICLR	16.3 B	$ 148.91	-2.55 %	$ 11.7 B	Irlanda
HTG Molecular Diagnostics HTGM	17.8 M	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	2.23 B	$ 101.99	-0.81 %	$ 6.88 B	USA
Global Cord Blood Corporation CO	8.53 B	-	-	$ 399 M	China
Fluidigm Corporation FLDM	325 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	6.19 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	975 M	-	0.12 %	$ 80.1 M	China
DermTech DMTK	122 M	-	-11.32 %	$ 2.94 M	USA
NeoGenomics NEO	1.36 B	$ 10.82	-4.33 %	$ 1.39 B	USA
Natera NTRA	2.4 B	$ 215.8	-2.84 %	$ 29.5 B	USA
Charles River Laboratories International CRL	7.14 B	$ 182.78	-1.63 %	$ 9.06 B	USA
PRA Health Sciences, Inc. PRAH	4.18 B	-	-	$ 10.7 B	USA
Pacific Biosciences of California PACB	784 M	$ 1.4	-13.85 %	$ 420 M	USA
Medpace Holdings MEDP	1.98 B	$ 455.2	-0.76 %	$ 13.1 B	USA
Mettler-Toledo International MTD	3.71 B	$ 1 154.6	-2.19 %	$ 23.8 B	Schweiz
Exact Sciences Corporation EXAS	5.86 B	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	707 M	$ 4.63	-1.39 %	$ 429 M	USA
National Research Corporation NRC	135 M	$ 19.56	-0.96 %	$ 438 M	USA
Personalis PSNL	334 M	$ 10.54	-12.93 %	$ 941 M	USA
Koninklijke Philips N.V. PHG	26.9 B	$ 26.17	0.67 %	$ 24.8 B	Niderland
Senseonics Holdings SENS	126 M	$ 6.63	-5.49 %	$ 277 M	USA
QIAGEN N.V. QGEN	6.28 B	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	564 M	-	-	$ 2.69 B	USA
Biomerica BMRA	5.94 M	$ 2.15	0.23 %	$ 4.94 M	USA
Laboratory Corporation of America Holdings LH	18.4 B	$ 266.2	1.95 %	$ 22.1 B	USA
Twist Bioscience Corporation TWST	642 M	$ 68.92	-6.78 %	$ 4.12 B	USA
Thermo Fisher Scientific TMO	110 B	$ 474.12	-1.65 %	$ 179 B	USA
Trinity Biotech plc TRIB	103 M	$ 0.67	-1.96 %	$ 241 M	Irlanda
Motus GI Holdings MOTS	7.22 M	-	-34.28 %	$ 263 K	Israel
Waters Corporation WAT	5.08 B	$ 367.04	-2.49 %	$ 21.9 B	USA
Neogen Corporation NEOG	3.44 B	$ 8.99	-1.48 %	$ 1.95 B	USA
Quest Diagnostics Incorporated DGX	16.2 B	$ 201.12	2.53 %	$ 22.3 B	USA